Lupin Limited — Others, 01-08-2025: News Verification

Lupin has addressed recent market speculation regarding U.S. government letters sent to global drug majors concerning lower drug prices. The company clarifies it has not received any such letter and confirms there is no material impact from this news on its business. Lupin also verified official U.S. government information, which does not list the company among those that received correspondence. This update should alleviate investor concerns about the potential impact of this news on Lupin's operations.